Omnipaque 240 Redi-Unit Interactions
There are 330 drugs known to interact with Omnipaque 240 Redi-Unit (iohexol), along with 2 disease interactions. Of the total drug interactions, 268 are major, and 62 are moderate.
- View all 330 medications that may interact with Omnipaque 240 Redi-Unit
- View Omnipaque 240 Redi-Unit disease interactions (2)
Most frequently checked interactions
View interaction reports for Omnipaque 240 Redi-Unit (iohexol) and the medicines listed below.
- amoxicillin
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- benzoyl peroxide topical
- Betadine Aerosol Spray (povidone iodine topical)
- Breo Ellipta (fluticasone / vilanterol)
- budesonide
- cefdinir
- Clindagel (clindamycin topical)
- Colace (docusate)
- CoQ10 (ubiquinone)
- Coreg (carvedilol)
- Coumadin (warfarin)
- Curcumin 95 (turmeric)
- dexamethasone
- Dotarem (gadoterate meglumine)
- doxycycline
- Eliquis (apixaban)
- Entresto (sacubitril / valsartan)
- erythromycin
- famotidine
- finasteride
- Flonase (fluticasone nasal)
- Flovent HFA (fluticasone)
- Gadavist (gadobutrol)
- Gleevec (imatinib)
- itraconazole
- Jardiance (empagliflozin)
- Keytruda (pembrolizumab)
- Lasix (furosemide)
Omnipaque 240 Redi-Unit disease interactions
There are 2 disease interactions with Omnipaque 240 Redi-Unit (iohexol) which include:
Report options
QR code containing a link to this page
More about Omnipaque 240 Redi-Unit (iohexol)
- Compare alternatives
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: non-ionic iodinated contrast media
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.